29
Participants
Start Date
February 18, 2019
Primary Completion Date
January 10, 2024
Study Completion Date
January 10, 2024
OTX-TKI
OTX-TKI is a dried polyethylene glycol-based hydrogel fiber containing dispersed microcrystals of a small molecule tyrosine kinase inhibitor (TKI).
OTX-TKI
OTX-TKI is a dried polyethylene glycol-based hydrogel fiber containing dispersed microcrystals of a small molecule tyrosine kinase inhibitor (TKI).
OTX-TKI
OTX-TKI is a dried polyethylene glycol-based hydrogel fiber containing dispersed microcrystals of a small molecule tyrosine kinase inhibitor (TKI).
OTX-TKI
OTX-TKI is a dried polyethylene glycol-based hydrogel fiber containing dispersed microcrystals of a small molecule tyrosine kinase inhibitor (TKI).
Anti-VEGF
Standard of care therapy used to block vascular endothelial growth factor
OTX-TKI
OTX-TKI is a dried polyethylene glycol-based hydrogel fiber containing dispersed microcrystals of a small molecule tyrosine kinase inhibitor (TKI).
Anti-VEGF
Standard of care therapy used to block vascular endothelial growth factor
Ocular Therapeutix, Inc., Sydney
Ocular Therapeutiux, Inc., Sydney
Ocular Therapeutiux, Inc., Sydney
Ocular Therapeutix, Inc., Adelaide
Ocular Therapeutix, Inc., Albury
Ocular Therapeutix, Inc., Melbourne
Lead Sponsor
Ocular Therapeutix, Inc.
INDUSTRY